Phenylethanolamine n-methyltransferase gene polymorphisms and adverse outcomes in acute kidney injury

Nephron - Clinical Practice

Volumn 114, Issue 4, 2010, Pages

  Alam, Ahsan ^a   O'Connor, Daniel T ^c   Perianayagam, Mary C ^b   Kolyada, Alexey Y ^b   Chen, Yuqing ^c   Rao, Fangwen ^c   Mahata, Manjula ^c   Mahata, Sushil ^c   Liangos, Orfeas ^b   Jaber, Bertrand L ^b  

^a TUFTS MEDICAL CENTER   (United States)

^b ST ELIZABETH'S MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Acute kidney injury; Mortality; Phenylethanolamine N methyltransferase; Single nucleotide polymorphisms

Indexed keywords

ADRENALIN; CATECHOLAMINE; PHENYLETHANOLAMINE N METHYLTRANSFERASE;

ADRENALIN URINE LEVEL; ADRENERGIC SYSTEM; ADULT; AGED; ALLELE; ARTICLE; CASE CONTROL STUDY; CATECHOLAMINE URINE LEVEL; CAUCASIAN; CONTROLLED STUDY; DIALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HAPLOTYPE; HEMODYNAMICS; HUMAN; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OLIGURIA; PRIORITY JOURNAL; PROMOTER REGION; SHOCK; SINGLE NUCLEOTIDE POLYMORPHISM;

ACUTE KIDNEY INJURY; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; HAPLOTYPES; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; PHENYLETHANOLAMINE N-METHYLTRANSFERASE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; RENAL DIALYSIS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 74249121124     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000276577     Document Type: Article

References (16)

1. Nash K, Hafeez A, Hou S: Hospital-acquired renal insufficiency. Am J Kidney Dis 2002; 39: 930-936. (Pubitemid 34454211)
2. Mehta RL, Pascual MT, Soroko S, Savage BR, Himmelfarb J, Ikizler TA, Paganini EP, Chertow GM: Spectrum of acute renal failure in the intensive care unit: the Picard experience. Kidney Int 2004; 66: 1613-1621. (Pubitemid 39298397)
3. Silvester W, Bellomo R, Cole L: Epidemiology, management, and outcome of severe acute renal failure of critical illness in Australia. Crit Care Med 2001; 29: 1910-1915. (Pubitemid 32980400)
4. Wong DL: Epinephrine biosynthesis: hormonal and neural control during stress. Cell Mol Neurobiol 2006; 26: 891-900.
5. Axelrod J, Reisine TD: Stress hormones: their interaction and regulation. Science 1984; 224: 452-459. (Pubitemid 14134739)
6. Goldstein DS, Eisenhofer G, Kopin IJ: Clinical catecholamine neurochemistry: a legacy of Julius Axelrod. Cell Mol Neurobiol 2006; 26: 695-702.
7. Hou SH, Bushinsky DA, Wish JB, Cohen JJ, Harrington JT: Hospital-acquired renal insufficiency: a prospective study. Am J Med 1983; 74: 243-248. (Pubitemid 13192180)
8. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A: Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007; 11:R31. (Pubitemid 46604959)
9. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G: 2001 SCCM/ESICM/ ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31: 1250-1256. (Pubitemid 36444440)
10. Ronaghi M: Pyrosequencing sheds light on DNA sequencing. Genome Res 2001; 11: 3-11. (Pubitemid 32117949)
11. Sasaoka T, Kaneda N, Kurosawa Y, Fujuta K, Nagatsu T: Structure of human phenylethanolamine N-methytransferase gene: existence of two types of mRNA with different transcription initiation sites. Neurochem Int 1989; 15: 555-565.
12. Halperin E, Eskin E: Haplotype reconstruction from genotype data using imperfect phylogeny. Bioinformatics 2004; 20: 1842-1849. (Pubitemid 39199048)
13. Haase-Fielitz A, Haase M, Bellomo R, Lambert G, Matalanis G, Story D, Doolan L, Buxton B, Gutteridge G, Luft FC, Schunck WH, Dragun D: Decreased catecholamine degradation associates with shock and kidney injury after cardiac surgery. J Am Soc Nephrol 2009; 20: 1393-1403.
14. Salem RM, Cadman PE, Chen Y, Rao F, Wen G, Hamilton BA, Rana BK, Smith DW, Stridsberg M, Ward HJ, Mahata M, Mahata SK, Bowden DW, Hicks PJ, Freedman BI, Schork NJ, O'Connor DT: Chromogranin a polymorphisms are associated with hypertensive renal disease. J Am Soc Nephrol 2008; 19: 600-614. (Pubitemid 351355404)
15. Rao F, Wessel J, Wen G, Zhang L, Rana BK, Kennedy BP, Greenwood TA, Salem RM, Chen Y, Khandrika S, Hamilton BA, Smith DW, Holstein-Rathlou NH, Ziegler MG, Schork NJ, O'Connor DT: Renal albumin excretion: twin studies identify influences of heredity, environment, and adrenergic pathway polymorphism. Hypertension 2007; 49: 1015-1031. (Pubitemid 351664306)
16. Perianayagam MC, Liangos O, Kolyada AY, Wald R, MacKinnon RW, Li L, Rao M, Balakrishnan VS, Bonventre JV, Pereira BJ, Jaber BL: NADPH oxidase p22phox and catalase gene variants are associated with biomarkers of oxidative stress and adverse outcomes in acute renal failure. J Am Soc Nephrol 2007; 18: 255-263. (Pubitemid 46053437)